Business Description
![Celyad Oncology SA Celyad Oncology SA logo](https://static.gurufocus.com/logos/0C0000A5LN.png?14)
Celyad Oncology SA
ISIN : BE0974260896
Compare
Compare
Traded in other countries / regions
CYAD.Belgium1C0.Germany0QFK.UKCYADY.USA IPO Date
2013-07-05Description
Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of innovative technologies for chimeric antigen receptor T-cell (CAR T) therapies. The company focuses on solid tumors and hematological malignancies. The firm has CYAD-01 and CYAD-02 programs in the pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CAR-T Cell, THINK, CYAD01 - Deplethink, CYAD02 - Cycle1, CwalityCAR, CYAD-101, and new engagers. The firm has Cardiology and Immuno-oncology operating segments. It generates majority of its revenue from Cardiology segment.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.64 | |||||
9-Day RSI | 40.17 | |||||
14-Day RSI | 40.97 | |||||
6-1 Month Momentum % | -38.98 | |||||
12-1 Month Momentum % | -46.27 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History |
---|
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Celyad Oncology SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.62 | ||
Beta | 2.1 | ||
Volatility % | 62.56 | ||
14-Day RSI | 40.97 | ||
14-Day ATR (€) | 0.017877 | ||
20-Day SMA (€) | 0.26605 | ||
12-1 Month Momentum % | -46.27 | ||
52-Week Range (€) | 0.231 - 1.28 | ||
Shares Outstanding (Mil) | 41.43 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Celyad Oncology SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Celyad Oncology SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Celyad Oncology SA Frequently Asked Questions
What is Celyad Oncology SA(XBRU:CYAD)'s stock price today?
The current price of XBRU:CYAD is €0.26. The 52 week high of XBRU:CYAD is €1.28 and 52 week low is €0.23.
When is next earnings date of Celyad Oncology SA(XBRU:CYAD)?
The next earnings date of Celyad Oncology SA(XBRU:CYAD) is 2024-08-02 Est..
Does Celyad Oncology SA(XBRU:CYAD) pay dividends? If so, how much?
Celyad Oncology SA(XBRU:CYAD) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |